Concord Medical Announces Result of 2024 Annual General Meeting

Concord Medical Announces Result of 2024 Annual General Meeting

BEIJING, Jan. 6, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced...

I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritization The Company has completed enrollment of a dose escalation study of givastomig in combination with...

Govee Announces New Lighting Technology for Elevated Living Experiences at CES 2025

Govee Announces New Lighting Technology for Elevated Living Experiences at CES 2025

LAS VEGAS, Jan. 6, 2025 /PRNewswire/ -- Govee, a global leader in smart ambient lighting innovation, is launching its new AI-powered Gaming Pixel Light, Mini Panel Lights, and the Table Lamp 2 Pro x Sound by JBL at Govee's CES 2025 experience at...

"Rock a New Era": Roborock Revolutionises Smart Home Cleaning at CES 2025 with robotic arm equipped Saros Z70

"Rock a New Era": Roborock Revolutionises Smart Home Cleaning at CES 2025 with robotic arm equipped Saros Z70

LAS VEGAS, Jan. 6, 2025 /PRNewswire/ -- Roborock, a global leader in home robotics engineered to simplify daily life, unveils the Saros Z70, the world's first mass-produced* robot vacuum cleaner equipped with an OmniGrip intelligent and foldable...

PARAMOUNT PICTURES ANNOUNCES SONIC THE HEDGEHOG FILM FRANCHISE ZOOMS PAST $1 BILLION IN WORLDWIDE BOX OFFICE GROSS

PARAMOUNT PICTURES ANNOUNCES SONIC THE HEDGEHOG FILM FRANCHISE ZOOMS PAST $1 BILLION IN WORLDWIDE BOX OFFICE GROSS

The third film in the series, Sonic the Hedgehog 3, recently surpassed $100M at the international box office, and has earned over $187M domestically for a cumulative worldwide gross to-date of over $312M HOLLYWOOD, Calif., Jan. 6, 2025 /PRNewswire/...

AirNet Announces Change of Auditor

AirNet Announces Change of Auditor

BEIJING, Jan. 3, 2025 /PRNewswire/ -- AirNet Technology Inc., formerly known as AirMedia Group Inc. ("AirNet" or the "Company") (Nasdaq: ANTE), today announced the appointment of Assentsure PAC ("Assentsure") as the Company's independent registered...

Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene

Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene

CAMBRIDGE, Mass., Jan. 3, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), today announced that BeiGene. Ltd. has exercised its exclusive option to acquire global...

OneConstruction Group Limited Announces Closing of Initial Public Offering

OneConstruction Group Limited Announces Closing of Initial Public Offering

NEW YORK, Jan. 3, 2025 /PRNewswire/ -- OneConstruction Group Limited ("OneConstruction Group" or the " Company "), a structural steelwork contractor in Hong Kong, today announced the closing of its initial public offering of 1,750,000 ordinary...

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Jan. 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across North America, Asia, Europe and the Middle East NEWPORT BEACH, Calif., Jan. 3, 2025 /PRNewswire/ -- CathWorks, a global leader in medical device digital health innovations, announced...

  • 1
  • ...
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • ...
  • 48
  • menu
    menu